SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0000950137-03-005991
Filing Date
2003-11-14
Accepted
2003-11-14 16:59:22
Documents
8
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-QSB c81033e10qsb.txt 10QSB 51240
3 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION c81033exv3w1.txt EX-3.1 90396
4 AMENDED AND RESTATED 1995 OMNIBUS INCENTIVE PLAN c81033exv10w1.txt EX-10.1 72775
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER-302 c81033exv31w1.txt EX-31.1 3271
6 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER-302 c81033exv31w2.txt EX-31.2 3265
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER-906 c81033exv32w1.txt EX-32.1 1280
8 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER-906 c81033exv32w2.txt EX-32.2 1273
9 RISK FACTORS c81033exv99w1.txt EX-99.1 27647
  Complete submission text file 0000950137-03-005991.txt   253872
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 000-16929 | Film No.: 031005664
SIC: 2834 Pharmaceutical Preparations